Healthcare › Medical Distribution

Cencora, Inc. (COR) Stock Overview

Market Cap: $64.53B

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.

Mar 19, 2026$331.74

1Y +24.8%

Rewards

★Cencora, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
★Cencora, Inc. scores 97/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
★Free cash flow has grown at a 13.3% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

⚠Gross margin of 3.6% is low, suggesting a competitive or commodity-like market with limited pricing power.
⚠FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
⚠Trailing P/E of 39.8x is 38% above the historical average of 29.0x — the stock trades at a premium to its own history.

COR Key Valuation Metrics

Learn more →

Free Cash Flow

$3.46B

FCF Yield

5.37%

Trailing P/E

39.82

Forward P/E

16.89

ROIC

25.33%

ROE

74.15%

Gross Margin

3.61%

PEG Ratio

2.69

Debt / Equity

4.73

Interest Coverage

N/A

Net Debt / EBITDA

1.64

Dividend Yield

0.72%

COR Historical Fundamentals

Learn more →

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

COR $1 Retained Earnings Test

Learn more →

Market Value

$8.81

created per $1 retained

Exceptional Value Creator

Earning Power

$-0.45

created per $1 retained

Earning Power Declined

Σ Retained

$3.56B

Δ Market Cap

+$31.33B

Δ Earning Power

$-1.61B

Buffett's "$1 Test": For every $1 retained, how much value did management create?
Market Value = market's verdict (mood-sensitive) · Earning Power = owner earnings / discount rate (mood-independent)

COR Discounted Cash Flow (DCF) Analysis

Learn more →

93.7% Overvalued

Price is 93.7% above estimated fair value

Current Price: $331.74

Strongly undervalued

Fairly valued

Strongly overvalued

Fair Value: $171.26

Strongly undervalued

Undervalued

Fairly valued

Overvalued

Strongly overvalued

Parameter	Min (Bear)Value	BaseValue	Max (Bull)Value
Initial Cash Flow
Growth Rate (Yr 1-5)	%	%	%
Growth Rate (Yr 6-10)	%	%	%
Terminal Growth Rate	%	%	%
Discount Rate	%	%	%
	Bear Case $105.61 Implied EV: $28.70B	Base Case $171.26 Implied EV: $41.47B	Bull Case $236.08 Implied EV: $54.08B

Reverse DCF — Market-Implied Growth

Learn more →

What growth rate is the market pricing in at $332?

+19.3%

Market-Implied Owner Earnings Growth

Standard FCF implies +8.4%

The market implies +19.3% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.4%, reflecting heavy growth investment.

COR Economic Moat Score

Learn more →

97/100

Wide Moat

70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

COR Forensic Accounting

Learn more →

-2.72

Unlikely Manipulator

Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

COR Management & Board

Learn more →

Dr. Robert P. Mauch Ph.D., PharmD

President, CEO & Director · Age 58

$6.26M

total pay

Mr. James F. Cleary Jr.

Executive VP & CFO · Age 62

$2.72M

total pay

Ms. Elizabeth S. Campbell J.D.

Executive VP & Chief Legal Officer · Age 50

$2.28M

total pay

Ms. Silvana Battaglia

Executive VP & Chief Human Resources Officer · Age 57

$1.96M

total pay

Mr. Lazarus Krikorian

Senior VP, Chief Accounting Officer & Corporate Controller · Age 60

Mr. Pawan Singh Verma

Executive VP and Chief Data & Information Officer · Age 48

Mr. Bennett S. Murphy

Senior VP Of Investor Relations & Enterprise Productivity and Treasury

Mr. Richard Tremonte

EVP and President of U.S. Pharmaceuticals & Animal Health

Mr. Juan Guerra

EVP & President of International Business Group

Mr. François Mandeville

Executive VP and Chief Strategy and M&A Officer

COR Ownership

Learn more →

Insiders 4.2%Institutions 96.9%

No. of Institutional Holders1,977

High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

COR Insider Buying Activity

Learn more →

Buys (3M)

Buys (12M)

CLYBURN FRANKLIN KING JR.

Director

$1,043

@ $260.75 · 2025-03-11

Open market purchases · includes direct & indirect ownership · excludes option exercises

COR Insider Selling Activity

Learn more →

Sells (3M)

Sells (12M)

Total value (12M): $59.56M

MAUCH ROBERT P.

Chief Executive Officer

$1.35M

@ $358.94 · 2026-02-20

MAUCH ROBERT P.

Chief Executive Officer

$479,160

@ $359.46 · 2026-02-18

MAUCH ROBERT P.

Chief Executive Officer

$1.81M

@ $354.73 · 2026-01-20

CAMPBELL ELIZABETH S

Officer

$1.15M

@ $342.10 · 2025-12-19

BATTAGLIA SILVANA

Officer

$578,565

@ $345.00 · 2025-12-19

MAUCH ROBERT P.

Chief Executive Officer

$1.75M

@ $343.45 · 2025-12-18

KRIKORIAN LAZARUS

Officer

$1.38M

@ $343.23 · 2025-12-17

MAUCH ROBERT P.

Chief Executive Officer

$1.87M

@ $366.64 · 2025-11-18

MAUCH ROBERT P.

Chief Executive Officer

$1.67M

@ $326.80 · 2025-10-20

CAMPBELL ELIZABETH S

Officer

$590,846

@ $313.28 · 2025-10-01

MAUCH ROBERT P.

Chief Executive Officer

$1.48M

@ $290.00 · 2025-09-18

COLLIS STEVEN H

Officer and Director

$9.09M

@ $289.86 · 2025-09-16

COLLIS STEVEN H

Officer and Director

$4.23M

@ $289.98 · 2025-08-19

MAUCH ROBERT P.

Chief Executive Officer

$1.46M

@ $293.53 · 2025-08-18

COLLIS STEVEN H

Officer and Director

$4.27M

@ $292.67 · 2025-07-22

MAUCH ROBERT P.

Chief Executive Officer

$1.46M

@ $294.11 · 2025-07-18

COLLIS STEVEN H

Officer and Director

$4.27M

@ $292.62 · 2025-06-24

BATTAGLIA SILVANA

Officer

$1.21M

@ $297.40 · 2025-06-18

MAUCH ROBERT P.

Chief Executive Officer

$1.47M

@ $295.30 · 2025-06-18

KRIKORIAN LAZARUS

Officer

$866,881

@ $288.96 · 2025-05-29

COLLIS STEVEN H

Officer and Director

$4.28M

@ $293.84 · 2025-05-20

MAUCH ROBERT P.

Chief Executive Officer

$1.45M

@ $291.43 · 2025-05-19

GREENBERG LON R

Director

$837,150

@ $279.05 · 2025-05-14

COLLIS STEVEN H

Officer and Director

$4.11M

@ $281.81 · 2025-04-22

MAUCH ROBERT P.

Chief Executive Officer

$1.44M

@ $289.33 · 2025-04-21

COLLIS STEVEN H

Officer and Director

$3.93M

@ $269.51 · 2025-03-25

CAMPBELL ELIZABETH S

Officer

$1.11M

@ $268.28 · 2025-03-24

MAUCH ROBERT P.

Chief Executive Officer

$1.30M

@ $260.93 · 2025-03-18

KRIKORIAN LAZARUS

Officer

$520,120

@ $260.06 · 2025-03-10

MAUCH ROBERT P.

Chief Executive Officer

$1.27M

@ $255.00 · 2025-03-03

COLLIS STEVEN H

Officer and Director

$3.66M

@ $251.08 · 2025-02-27

BATTAGLIA SILVANA

Officer

$1.21M

@ $242.24 · 2025-02-21

BATTAGLIA SILVANA

Officer

$383,792

@ $228.72 · 2024-12-20

KRIKORIAN LAZARUS

Officer

$454,754

@ $250.42 · 2024-12-03

COLLIS STEVEN H

Officer and Director

$12.20M

@ $243.97 · 2024-11-25

COLLIS STEVEN H

Officer and Director

$5.21M

@ $242.16 · 2024-11-19

COLLIS STEVEN H

Officer and Director

$5.07M

@ $235.80 · 2024-10-22

COLLIS STEVEN H

Chief Executive Officer

$5.18M

@ $241.01 · 2024-09-17

COLLIS STEVEN H

Chief Executive Officer

$2.57M

@ $239.13 · 2024-08-20

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

COR 🎭 Mr. Market's Mood

Learn more →

😐Neutral(46/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

COR ⚖️ Buffett Signal

Learn more →

⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (46)

COR Investment Checklist & Notes

Learn more →

Do I understand this business?

Does it have a durable competitive advantage (moat)?

Is management honest and competent?

Is management allocating capital rationally?

Is the price reasonable (margin of safety)?

Is this within my circle of competence?

Auto-saved • Last updated: 3/20/2026, 4:30:11 AM

COR Insider Buying Activity

Learn more →

Buys (3M)

Buys (12M)

CLYBURN FRANKLIN KING JR.

Director

$1,043

@ $260.75 · 2025-03-11

Open market purchases · includes direct & indirect ownership · excludes option exercises

COR Insider Selling Activity

Learn more →

Sells (3M)

Sells (12M)

Total value (12M): $59.56M

MAUCH ROBERT P.

Chief Executive Officer

$1.35M

@ $358.94 · 2026-02-20

MAUCH ROBERT P.

Chief Executive Officer

$479,160

@ $359.46 · 2026-02-18

MAUCH ROBERT P.

Chief Executive Officer

$1.81M

@ $354.73 · 2026-01-20

CAMPBELL ELIZABETH S

Officer

$1.15M

@ $342.10 · 2025-12-19

BATTAGLIA SILVANA

Officer

$578,565

@ $345.00 · 2025-12-19

MAUCH ROBERT P.

Chief Executive Officer

$1.75M

@ $343.45 · 2025-12-18

KRIKORIAN LAZARUS

Officer

$1.38M

@ $343.23 · 2025-12-17

MAUCH ROBERT P.

Chief Executive Officer

$1.87M

@ $366.64 · 2025-11-18

MAUCH ROBERT P.

Chief Executive Officer

$1.67M

@ $326.80 · 2025-10-20

CAMPBELL ELIZABETH S

Officer

$590,846

@ $313.28 · 2025-10-01

MAUCH ROBERT P.

Chief Executive Officer

$1.48M

@ $290.00 · 2025-09-18

COLLIS STEVEN H

Officer and Director

$9.09M

@ $289.86 · 2025-09-16

COLLIS STEVEN H

Officer and Director

$4.23M

@ $289.98 · 2025-08-19

MAUCH ROBERT P.

Chief Executive Officer

$1.46M

@ $293.53 · 2025-08-18

COLLIS STEVEN H

Officer and Director

$4.27M

@ $292.67 · 2025-07-22

MAUCH ROBERT P.

Chief Executive Officer

$1.46M

@ $294.11 · 2025-07-18

COLLIS STEVEN H

Officer and Director

$4.27M

@ $292.62 · 2025-06-24

BATTAGLIA SILVANA

Officer

$1.21M

@ $297.40 · 2025-06-18

MAUCH ROBERT P.

Chief Executive Officer

$1.47M

@ $295.30 · 2025-06-18

KRIKORIAN LAZARUS

Officer

$866,881

@ $288.96 · 2025-05-29

COLLIS STEVEN H

Officer and Director

$4.28M

@ $293.84 · 2025-05-20

MAUCH ROBERT P.

Chief Executive Officer

$1.45M

@ $291.43 · 2025-05-19

GREENBERG LON R

Director

$837,150

@ $279.05 · 2025-05-14

COLLIS STEVEN H

Officer and Director

$4.11M

@ $281.81 · 2025-04-22

MAUCH ROBERT P.

Chief Executive Officer

$1.44M

@ $289.33 · 2025-04-21

COLLIS STEVEN H

Officer and Director

$3.93M

@ $269.51 · 2025-03-25

CAMPBELL ELIZABETH S

Officer

$1.11M

@ $268.28 · 2025-03-24

MAUCH ROBERT P.

Chief Executive Officer

$1.30M

@ $260.93 · 2025-03-18

KRIKORIAN LAZARUS

Officer

$520,120

@ $260.06 · 2025-03-10

MAUCH ROBERT P.

Chief Executive Officer

$1.27M

@ $255.00 · 2025-03-03

COLLIS STEVEN H

Officer and Director

$3.66M

@ $251.08 · 2025-02-27

BATTAGLIA SILVANA

Officer

$1.21M

@ $242.24 · 2025-02-21

BATTAGLIA SILVANA

Officer

$383,792

@ $228.72 · 2024-12-20

KRIKORIAN LAZARUS

Officer

$454,754

@ $250.42 · 2024-12-03

COLLIS STEVEN H

Officer and Director

$12.20M

@ $243.97 · 2024-11-25

COLLIS STEVEN H

Officer and Director

$5.21M

@ $242.16 · 2024-11-19

COLLIS STEVEN H

Officer and Director

$5.07M

@ $235.80 · 2024-10-22

COLLIS STEVEN H

Chief Executive Officer

$5.18M

@ $241.01 · 2024-09-17

COLLIS STEVEN H

Chief Executive Officer

$2.57M

@ $239.13 · 2024-08-20

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

COR Investment Checklist & Notes

Learn more →

Do I understand this business?

Does it have a durable competitive advantage (moat)?

Is management honest and competent?

Is management allocating capital rationally?

Is the price reasonable (margin of safety)?

Is this within my circle of competence?

Auto-saved • Last updated: 3/20/2026, 4:30:11 AM

Cencora, Inc. (COR) Stock Overview

Rewards

Risks

COR Key Valuation Metrics

COR Historical Fundamentals

COR $1 Retained Earnings Test

COR Discounted Cash Flow (DCF) Analysis

Reverse DCF — Market-Implied Growth

COR Economic Moat Score

COR Forensic Accounting

M-Score Trend

COR Management & Board

COR Ownership

COR Insider Buying Activity

COR Insider Selling Activity

COR 🎭 Mr. Market's Mood

COR ⚖️ Buffett Signal

Compare COR

COR Investment Checklist & Notes

COR Insider Buying Activity

COR Insider Selling Activity

COR Investment Checklist & Notes